New York State Common Retirement Fund
INZY

New York State Common Retirement Fund’s Inozyme Pharma INZY Stock Holding History

New York State Common Retirement Fund’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,403
Closed -$12.2K – 3262
2025
Q1 		$12.2K Hold
13,403
– – ﹤0.01% 3057
2024
Q4 		$37.1K Hold
13,403
– – ﹤0.01% 2936
2024
Q3 		$70.1K Hold
13,403
– – ﹤0.01% 2753
2024
Q2 		$59.8K Buy
13,403
+45
+0.3% +$218 ﹤0.01% 3046
2024
Q1 		$102K Buy
13,358
+57
+0.4% +$313 ﹤0.01% 2729
2023
Q4 		$56.7K Sell
13,301
-74
-0.6% -$263 ﹤0.01% 2956
2023
Q3 		$56.2K Sell
13,375
-3,725
-22% -$18.9K ﹤0.01% 2986
2023
Q2 		$95.2K Buy
+17,100
New +$101K ﹤0.01% 2888
2022
Q3 		– Sell
-117
Closed -$1K – 3363
2022
Q2 		$1K Sell
117
-3,717
-97% -$16.2K ﹤0.01% 3366
2022
Q1 		$16K Hold
3,834
– – ﹤0.01% 3299
2021
Q4 		$26K Sell
3,834
-6,619
-63% -$57.2K ﹤0.01% 3284
2021
Q3 		$121K Buy
10,453
+1,651
+19% +$25.7K ﹤0.01% 3080
2021
Q2 		$150K Sell
8,802
-3,498
-28% -$60.9K ﹤0.01% 3130
2021
Q1 		$244K Buy
12,300
+4,900
+66% +$108K ﹤0.01% 2760
2020
Q4 		$153K Buy
+7,400
New +$176K ﹤0.01% 2846

Other funds holding INZY

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

New York State Common Retirement Fund's INZY Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Inozyme Pharma (INZY) in Q2 2025, closing a stake of 13,403 shares — an estimated $12.2K sold.

New York State Common Retirement Fund first reported a position in INZY in Q4 2020 and held it in 15 quarters. The position peaked at $244K in Q1 2021. 86 funds tracked by Wall St. Rank hold INZY as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Inozyme Pharma position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 13,403 Inozyme Pharma shares in Q2 2025, an estimated $12.2K.
  • New York State Common Retirement Fund first reported a position in Inozyme Pharma in Q4 2020 and held it in 15 quarters.
  • New York State Common Retirement Fund's Inozyme Pharma position peaked at $244K in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.